By Nev Zubcevik, DO, Chief Medical Officer, Electrome
Electrome is pioneering brain-focused bioelectric medicine by using targeted electromagnetic stimulation to restore disrupted neural circuits, offering new hope for conditions like concussion, stroke, dementia, and depression (2,3).
Introduction
As bioelectric medicine advances from theory into mainstream clinical practice, nowhere is its promise more urgent than in brain health. Concussions, strokes, and neurodegenerative disorders remain devastating and costly, yet the brain is fundamentally an electrical system (5). By restoring disrupted bioelectric patterns, we may offer new hope to millions living with injury or decline.
Bioelectricity: The brain’s hidden code
From the firing of a neuron to the consolidation of a memory, the brain’s functions are orchestrated through electrical signals (1). When trauma or disease disrupts these patterns through inflammation, vascular injury, or synaptic decay, symptoms appear: memory loss, headaches, mood dysregulation, paralysis. Unlike many pharmaceuticals, bioelectric modulation targets the signaling itself, addressing root dysfunction rather than downstream effects.
Reconnecting the injured brain
At Electrome and partner institutions, teams are pioneering pulsed electromagnetic field (PEMF) therapies to accelerate neural repair and reduce neuroinflammation (6). Concussion and traumatic brain injury therapies have shown PEMF can stabilize the blood-brain barrier, reduce edema, and normalize disrupted circuits. Stroke recovery protocols demonstrate that by enhancing BDNF and IGF-1, stimulation promotes neuroplasticity and aids rehabilitation of movement and speech. In dementia and Alzheimer’s disease, frequency-tuned fields can improve default mode network function and memory consolidation, reducing cognitive decline. Neuromodulation approaches are also showing promise in depression and PTSD by regulating overactive fear circuits and strengthening resilience (4). Erik Nilsen PhD, CTO of Electrome states, “The brain isn’t just a chemical organ. It’s an electrical system. The future of treating brain injury and cognitive decline may lie not in pills, but in patterns.”
References
- Santarnecchi E, et al. Frequency-tuned transcranial stimulation improves memory in older adults. Sci Transl Med. 2022;14(630):eabe8620. Link
- Alzheimer’s Disease International. Dementia statistics. Link
- Next-Generation Bioelectric Medicine: Harnessing the Therapeutic Potential. Front Neurol. 2020;11:616529. Link
- Peeples L. The rise of bioelectric medicine sparks interest among researchers. PNAS. 2019;116(49):24379-24381. Link
- Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion Globally by 2032. Allied Market Research. 2024. Link
- Electrome Corporation. Precision Bioelectric Therapeutics. Link